Welcome to our dedicated page for Sleep Number SEC filings (Ticker: SNBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sleep Number Corporation SEC filings document its personalized sleep-products business, capital structure and public-company governance. Form 8-K disclosures cover operating results, Regulation FD investor presentations, amendments to its credit agreement, covenant and liquidity terms, financing arrangements, officer appointments, board changes and compensatory arrangements.
The company’s proxy materials describe director matters, executive compensation, equity awards and shareholder voting items. Together, the filings provide formal records for Sleep Number’s direct-to-consumer retail model, product and marketing strategy, debt obligations, internal reporting roles and governance practices.
Sleep Number Corporation furnished an investor presentation outlining a comprehensive turnaround and financial stabilization plan. The company reported 2025 net sales of $1.41 billion and adjusted EBITDA of $78.3 million, with an adjusted EBITDA margin of 5.5%, alongside a net loss of $132.0 million and free cash flow of $(17.7) million.
Management highlighted more than $185 million of annualized cost reductions already executed and plans for an additional $50 million of annualized cost actions in 2026, supporting a pro forma adjusted EBITDA margin of about 9.1%. The strategy centers on three “Sleep Number Shifts”: simplifying the product portfolio, modernizing marketing to improve return on investment, and expanding distribution across physical and digital channels.
The company is also addressing liquidity and capital structure, citing an amended and extended credit agreement and a net leverage ratio of 4.1x under its revolving credit facility as of year-end 2025. Leadership expects that a stabilized top line, consistent gross margins, and a lower fixed cost base can support a return to free cash flow generation in 2026.
Sleep Number Corporation reports a difficult 2025 and describes an aggressive turnaround while warning of substantial doubt about its ability to continue as a going concern. Net sales fell 16%, producing a $132 million net loss. Adjusted EBITDA was $78 million, a 5.5% margin, down 1.6 percentage points.
Management cut operating costs by $136 million in 2025, extending cumulative reductions to $308 million over three years and amended its credit agreement, now maturing in December 2027. Even so, the company expects to breach financial covenants and may lack liquidity without new capital, lender concessions and successful execution of its “Sleep Number Shifts” turnaround.
Sleep Number Corporation appointed Kelly F. Baker as Controller and Principal Accounting Officer, effective March 11, 2026. She had been serving in this role on an interim basis since July 21, 2025, and has been the Company’s Controller since February 2025.
Baker, 41, previously served as Controller at Miromatrix Medical, Inc. and held finance roles at Donaldson Company, The Tile Shop, and Virtual Radiologic Corporation. She began her career at PricewaterhouseCoopers, holds both bachelor’s and MBA degrees, and is a Certified Public Accountant. The Company states there are no related‑party transactions requiring disclosure.
Sleep Number Corporation reported a difficult 2025 with early signs of a turnaround. Full-year net sales were $1.41 billion, down 16%, as weak industry demand and lower store traffic weighed on results. The company posted a net loss of $132 million, much wider than the prior year’s $20 million loss, while adjusted EBITDA fell 35% to $78 million with a 5.5% margin, down 160 basis points.
Despite this, Sleep Number realized $185 million of annualized cost savings and exited the year with a pro forma adjusted EBITDA margin of about 9%. Management plans another $50 million of annualized fixed cost reductions in 2026 and highlights strong initial demand and higher margins for its new ComfortMode bed and broader product refresh.
Liquidity remains tight, with net cash used in operating activities of $3 million, free cash flow of negative $18 million, cash of $1.7 million, and borrowings of $588.2 million under its revolving credit facility. The leverage ratio under the credit agreement was 4.1x EBITDAR versus a 4.5x covenant maximum, and the company has engaged Guggenheim Securities to evaluate options to improve its capital structure.
Pacific Ridge Capital Partners, LLC filed a Schedule 13G reporting beneficial ownership of 1,145,612 shares of Sleep Number Corp common stock, representing 5.0% of the outstanding class as of the event date.
Pacific Ridge reports sole voting power over 704,330 shares and sole dispositive power over all 1,145,612 shares, with no shared voting or dispositive power. It certifies the Sleep Number shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
FMR LLC has filed a Schedule 13G reporting beneficial ownership of 2,129,875.54 shares of Sleep Number Corp common stock, representing 9.3% of the outstanding class as of the event date. The filing also attributes the same 2,129,875.54 shares and 9.3% interest to Abigail P. Johnson, with sole dispositive power but no voting or shared dispositive power reported for her. FMR LLC reports sole voting power over 2,125,213 shares and confirms the holdings were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Sleep Number.
Sleep Number Corporation entered into a three-year brand deal with Travis Kelce and TMK Enterprises LLC. The Athlete Parties will work with the company to promote the benefits of quality sleep and help expand its market reach.
Compensation to the Athlete Parties will include cash and a restricted stock unit award granted under Sleep Number’s 2020 Equity Incentive Plan, with vesting over three years. They also agreed to make open market purchases of Sleep Number common stock, aligning part of their interests with existing shareholders.
Sleep Number Corp executive vice president and chief financial officer Amy K. O'Keefe reported acquiring 69,742 shares of common stock in the form of restricted stock units on 12/15/2025. The award was recorded at a price of $0 per share.
Following this grant, she beneficially owns 69,742 shares directly, consisting of restricted stock units that will vest over time.
Sleep Number Corporation is registering 69,742 shares of common stock for issuance under a restricted stock unit inducement award to employee Amy K. O'Keefe. These shares will be delivered upon settlement of restricted stock units that are scheduled to be granted on December 15, 2025.
The award was approved by the company’s board of directors as an inducement material to the employee’s acceptance of employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement award will be issued outside of Sleep Number’s 2020 Equity Incentive Plan, and the filing also describes standard indemnification protections for directors and officers under Minnesota law and the company’s bylaws.
Sleep Number Corp (SNBR) insider equity update: Senior Vice President and Chief Supply Chain Officer Tanya C. Skogerboe reported equity activity effective 11/14/2025. On that date, 4,638 shares of Sleep Number common stock vested from restricted stock unit awards, and the reporting person covered the related estimated tax obligation in cash rather than by selling shares. Following the transaction, Skogerboe beneficially owned 47,877 shares of common stock directly and 2,517.4642 shares indirectly through a 401(k) plan, including 33,640 restricted stock units that vest over time.